CN106581565A - Traditional Chinese medicine composition for treating gallstones - Google Patents
Traditional Chinese medicine composition for treating gallstones Download PDFInfo
- Publication number
- CN106581565A CN106581565A CN201510663756.9A CN201510663756A CN106581565A CN 106581565 A CN106581565 A CN 106581565A CN 201510663756 A CN201510663756 A CN 201510663756A CN 106581565 A CN106581565 A CN 106581565A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- fructus
- medicine composition
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention provides traditional Chinese medicine composition for treating gallstones. The traditional Chinese medicine composition has a good effect, does not have toxic or side effects and can treat symptoms and root causes of gallstones and gallstones cannot relapse. The traditional Chinese medicine composition is prepared from Chinese herbal medicines in parts by weight as follows: 15 parts of radix bupleuri, 15 parts of radix scutellariae, 15 parts of radix curcumae, 15 parts of fructus aurantii, 15 parts of rhizoma curcumae longae, 15 parts of pericarpium citri reticulatae viride, 15 parts of rhubarb, 15 parts of radix paeoniae alba, 10 parts of fructus crataegi, 12 parts of fructus meliae toosendan, 30 parts of herba lysimachiae, 5 parts of rhizoma corydalis, 5 parts of caulis bambusae in taenia, 5 parts of rhizoma pinelliae, 5 parts of flos lonicerae, 5 parts of herba taraxaci, 5 parts of fructus forsythiae, 5 parts of herba artemisiae scopariae, 5 parts of fructus gardeniae and 5 parts of gentian.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition, especially a kind of Chinese medicine composition for treating cholelithiasis.
Background technology
Cholelithiasis sickness rate increases year by year in China, outstanding many with female middle-aged morbidity.According to the chemical composition analysis of calculus, cholelithiasises great majority are cholesterol calculus, and it is bile pigment calculuses that bile duct regulating liver-QI inner bag person calculus is most, is mostly primary cholelithiasis.With growth in the living standard, the change of dietary habit, the improvement of sanitary condition, the cholelithiasis disease of China is by being gradually converted into based on gallbladder cholesterol calculus based on the bile pigment calculuses with bile duct.Cholelithiasises are mainly cholesterol calculus or the Combination based on cholesterol stone is combined.
At present, the sickness rate of cholelithiasis is gradually increasing, and both at home and abroad the method for the treatment of cholelithiasis is varied, mainly based on operation.Injury of the operation to human body itself is very big, while operation is simply simple take out calculus, therefore, the relapse rate of calculus is also very high.
The content of the invention
The invention provides a kind of Chinese medicine composition for treating cholelithiasis, its effect is good, has no toxic side effect, without recurrence, can treating both the principal and secondary aspects of a disease treatment cholelithiasis, solve problems of the prior art.
The present invention is for the solution technical scheme that adopted of above-mentioned technical problem:A kind of Chinese medicine composition for treating cholelithiasis, it is characterised in that formed by the Chinese crude drug proportioning of following weight parts:15 parts of Radix Bupleuri, 15 parts of Radix Scutellariae, 15 parts of Radix Curcumae, 15 parts of Fructus Aurantii, 15 parts of Rhizoma Curcumae Longae, 15 parts of Pericarpium Citri Reticulatae Viride, 15 parts of Radix Et Rhizoma Rhei, 15 parts of the Radix Paeoniae Alba, 10 parts of Fructus Crataegi, 12 parts of Fructus Toosendan, 30 parts of Herba Lysimachiae, 5 parts of Rhizoma Corydalis, 5 parts of Caulis Bambusae In Taenia, 5 parts of the Rhizoma Pinelliae, 5 parts of Flos Lonicerae, 5 parts of Herba Taraxaci, 5 parts of Fructus Forsythiae, 5 parts of Herba Artemisiae Scopariae, 5 parts of Fructus Gardeniae, 5 parts of Radix Gentianae.
Prepare and instructions of taking:Decocting is boiled, and is taken in the morning and evening at twice.
Above-mentioned raw materials medicine is mixed, drug effect is mutually cooperateed with, cooperate, and fairly obvious for treating cholelithiasis curative effect, effective percentage is up to more than 95%.And formed using prepared from traditional Chinese medicines completely, nontoxic, have no side effect, short treating period, instant effect, expense are low.
Specific embodiment:A kind of Chinese medicine composition for treating cholelithiasis, it is characterised in that formed by the Chinese crude drug proportioning of following weight:Radix Bupleuri 15g, Radix Scutellariae 15g, Radix Curcumae 15g, Fructus Aurantii 15g, Rhizoma Curcumae Longae 15g, Pericarpium Citri Reticulatae Viride 15g, Radix Et Rhizoma Rhei 15g, Radix Paeoniae Alba 15g, Fructus Crataegi 10g, Fructus Toosendan 12g, Herba Lysimachiae 30g, Rhizoma Corydalis 5g, Caulis Bambusae In Taenia 5g, Rhizoma Pinelliae 5g, Flos Lonicerae 5g, Herba Taraxaci 5g, Fructus Forsythiae 5g, Herba Artemisiae Scopariae 5g, Fructus Gardeniae 5g, Radix Gentianae 5g.
Claims (1)
1. a kind of Chinese medicine composition for treating cholelithiasis, it is characterised in that formed by the Chinese crude drug proportioning of following weight parts:15 parts of Radix Bupleuri, 15 parts of Radix Scutellariae, 15 parts of Radix Curcumae, 15 parts of Fructus Aurantii, 15 parts of Rhizoma Curcumae Longae, 15 parts of Pericarpium Citri Reticulatae Viride, 15 parts of Radix Et Rhizoma Rhei, 15 parts of the Radix Paeoniae Alba, 10 parts of Fructus Crataegi, 12 parts of Fructus Toosendan, 30 parts of Herba Lysimachiae, 5 parts of Rhizoma Corydalis, 5 parts of Caulis Bambusae In Taenia, 5 parts of the Rhizoma Pinelliae, 5 parts of Flos Lonicerae, 5 parts of Herba Taraxaci, 5 parts of Fructus Forsythiae, 5 parts of Herba Artemisiae Scopariae, 5 parts of Fructus Gardeniae, 5 parts of Radix Gentianae.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510663756.9A CN106581565A (en) | 2015-10-15 | 2015-10-15 | Traditional Chinese medicine composition for treating gallstones |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510663756.9A CN106581565A (en) | 2015-10-15 | 2015-10-15 | Traditional Chinese medicine composition for treating gallstones |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106581565A true CN106581565A (en) | 2017-04-26 |
Family
ID=58552111
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510663756.9A Pending CN106581565A (en) | 2015-10-15 | 2015-10-15 | Traditional Chinese medicine composition for treating gallstones |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106581565A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108498607A (en) * | 2017-05-15 | 2018-09-07 | 苏州赵陈生物科技有限公司 | A kind of Chinese medicine composition for treating gall stone |
-
2015
- 2015-10-15 CN CN201510663756.9A patent/CN106581565A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108498607A (en) * | 2017-05-15 | 2018-09-07 | 苏州赵陈生物科技有限公司 | A kind of Chinese medicine composition for treating gall stone |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103845717B (en) | A kind of external traditional Chinese medicine oil and preparation method thereof | |
CN103394057A (en) | Traditional Chinese medicine composition for treating diarrhoea | |
CN102988616B (en) | Chinese medicinal composition for treating anemia | |
CN104606626A (en) | Traditional Chinese medicine used for treating gall-stone | |
CN103479947B (en) | The preparation method of control constipation medicine | |
CN102451449A (en) | Capsule for warming channel to remove coldness | |
CN104758529A (en) | Traditional Chinese medicine composition for treating common cold due to wind-cold | |
CN106581565A (en) | Traditional Chinese medicine composition for treating gallstones | |
CN102048935A (en) | Formula of traditional Chinese medicine for treating chronic rhinitis | |
CN103446555A (en) | Chinese medicinal composition for treating cholecystitis | |
CN103479952A (en) | Summer-heat relieving soup | |
CN104587123A (en) | Traditional Chinese medicine composition for treating dyspepsia | |
CN104398740A (en) | Traditional Chinese medicinal composition for treating difficult urination | |
CN103316280B (en) | Traditional Chinese medicine composition for treating colitis | |
CN106581563A (en) | Gallstone treatment traditional Chinese medicine composition | |
CN101897923A (en) | Chinese medicinal powder for treating nighttime lumbago | |
CN105055580A (en) | Traditional Chinese medicine for treating cold | |
CN103263516B (en) | Medicine for treating cholecystitis | |
CN106581562A (en) | Chinese medicinal composition for treatment of cholelithiasis | |
CN106581564A (en) | Traditional Chinese medicine composition for curing biliary calculus | |
CN104096136A (en) | Traditional Chinese medicine for treating chronic pancreatitis | |
CN103920099A (en) | Medicine composition for treating chronic cholecystitis | |
CN104367966A (en) | Traditional Chinese medicine composition for treating chronic bronchitis | |
CN104043065A (en) | Traditional Chinese medicine composition for treating malaria | |
CN109381664A (en) | A kind of Chinese medicine composition for treating gall stone |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170426 |